Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.

Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...

House Energy Chair Brett Guthrie said he hopes to revive the health legislation that was pushed out of the American Relief ...

Says that while the company offers customers 100% pass-through options, “a small number have historically elected other models.” Witty says “We ...

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

Jan. 16 at 1:45 p.m. ETUnitedHealth Group's Optum Rx unit made a commitment to pass through 100% of rebates negotiated with ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...

The pharmaceutical supply chain is a sector infamous for glacially slow adjustments, lackluster reform, lack of transparency ...

"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...